WHO vaccine-preventable diseases: monitoring system. 2017 global summary

Last updated 06-Sep-2017 (data as of 05-Sep-2017)
Next overall update 2018
EPI mother and child logo         
Select a country

Development status: Developing GNI / capita (US$): 15'5601 Infant (under 12 months) mortality rate: 82
GDP / capita (US$): 24'3691 Child (under 5 years) mortality rate: 112

Population data in thousands3

  2016  2015  2014  2013  2012  2000  1990  1980 
Total population 55  54  54  53  53  45  41  43 
Births
Surviving infants
Pop. less than 5 years
Pop. less than 15 years 14  14  14  14  14  14  13  16 
Female 15-49 years 14  14  14  14  14  12  10  11 

Number of reported cases

(Click for retrospective incidence data for Saint Kitts and Nevis)
Diphtheria
ChartChart
 
Japanese encephalitis
 
Measles
ChartChart ChartChart
  80  305 
Mumps
ChartChart
 
Pertussis
ChartChart
 
Polio*
ChartChart
 
Rubella
ChartChart
 
Rubella (CRS)
ChartChart
 
Tetanus (neonatal)
ChartChart
 
Tetanus (total)**
ChartChart
 
Yellow fever
 
* Polio refers to all polio cases (indigenous or imported), including polio cases caused by vaccine derived polio viruses (VDPV). For disaggregated data please click on this hyperlink: https://extranet.who.int/polis/public/CaseCount.aspx
it does not include cases of vaccine-associated paralytic polio (VAPP) and cases of non polio acute flaccid paralysis [AFP]).
** Neonatal Tetanus and Total Tetanus cases equality may be the result from a lack of non-Neonatal Tetanus surveillance system.

Percentage target population vaccinated by antigen

Hovering over an antigen reveals its fuller definition
  Most recent coverage survey4  

Official country estimates5

  (Click for retrospective coverage estimates data for Saint Kitts and Nevis)
Vaccine year result method % card seen                                                
BCG          96  95  99  94  95  99* 
DTP1          92  92  99  84  96  99* 
DTP3          98  94  98  97  99*  99  99*  56 
DTP4          94  85  97 
IPV1          93  99* 
HepB_BD          98  99* 
HepB3          98  94  98  97  99*  99* 
Hib3          98  94  98  97  99*  12 
JapEnc         
MCV1          98  95  93  99  95  99*  99* 
MCV2          97  90  90  94  90  99 
MenA         
PCV1         
PCV2         
PCV3         
Pol3          99*  91  96  97  99*  99  99*  76 
Rota1         
RotaC         
RCV1          98  95  93  99  95 
TT2plus         
PAB          92 
VAD1         
YFV         
* indicates the country reported above 100% coverage.

  Next update: Mid-July 2018

WHO-UNICEF estimates6

  (Click for full retrospective WHO-UNICEF coverage estimates data for Saint Kitts and Nevis)
BCG
ChartChart
  96  95  99  94  95  99  80 
DTP1
ChartChart
  99  96  99  99  99  99  99  79 
DTP3
ChartChart
  97  93  97  96  97  98  99  56 
HepB3
ChartChart
  98  94  98  97  98  99 
HepB_BD
ChartChart
  98  18 
Hib3
ChartChart
  98  94  98  97  98  12 
IPV1
  93 
MCV1
ChartChart
  98  95  93  99  95  99  99 
MCV2
ChartChart
  97  90  90  94  90  99 
PCV3
 
Pol3
ChartChart
  99  90  95  96  97  98  99  76 
RCV1
ChartChart
  98  95  93  99  95  99  99 
RotaC
 

Click for WHO-UNICEF coverage estimates data for PAB time series.

Number of districts in the country 17  Proportion of
districts reporting
DTP3 coverage:
% of coverage reports received at national
level vs number of reports expected
100 
   
/
|
|
\
Greater or equal to 90% 100
From 80 to 89% 0
From 50 to 79% 0
Less than 50% 0
Proportion of districts
not reporting DTP3 coverage
0
DTP3 reported coverageDTP3 reported coverage

Immunization Schedule (2016 or latest available)

Hovering over an antigen reveals its fuller definition
Vaccine Schedule Entire country Comment
BCG 4 weeks; Yes
DT 2, 4, 6, 18 months; 4.5 years; No children with special conditions
DTwP 18 months; 4-5 years; Yes
DTwPHibHepB 2, 4, 6 months; Yes
HepB_Adult 1st contact; +4 weeks; +6 months; No special groups
HepB_Pediatric birth;
IPV 2 months;
MMR 12, 18 months; Yes
OPV 4, 6, 18 months; 4.5, 15-16 years; Yes
Td 15-16 years; Yes
YF No travelers to endemic countries

Immunizaton indicators

Indicator Expected answer 2016  2015  2014  2013  2012  2011  2010 

Planning and management

Has the country a Multi-Year Plan (MYP) for immunization? Yes/No/NR Yes  No  Yes  Yes  Yes  Yes  No 
What years does the MYP cover? number 2017-2021    2'015    2010-2011     
Nº of districts with microplans that include activities to raise immunization coverage number 17  17  17  17  17  17  17 

System performance

Total Nº districts in country number 17  17  17  17  17  17  17 
Nº districts with DTP3 coverage >=80% number 17  15  17  16  17  17  17 
% of districts with DTP3 coverage >=80% From 0 to 100% 100  88  100  94  100  100  100 
Nº districts with measles (MCV1) coverage >=95% number 15  11  12  13  17  17 
% of districts with MCV1 coverage >=95% From 0 to 100% 88  47  65  71  76  100  100 

Safety

Has the country a vaccine adverse events review committee? Yes/No/NR/ND No  No  Yes  No  Yes  Yes  Yes 
Is there a national system to monitor adverse events following immunization (AEFI)? Yes/No/NR Yes  Yes  Yes    Yes    Yes 

Finance

% of Immunization expenditure financed, using Government funds? From 0 to 100%   98  95  100  100  100  100 

National Immunization Advisory Mechanism

Has the country a standing technical advisory group on immunization (NITAG)? Yes/No/NR No  NA  No  No  No  No  No 

Sources

 1  "The 2017 World Bank Development Indicators Online", GDP per capita is PPP adjusted.
 2  World Health Statistics 2016, data for 2015
 3  "United Nations, Population Division. The World Population Prospects - the 2017 revision". New York, 2017.
 4  UNICEF/WHO survey database
 5  If no official estimate is available, the administrative coverage is reported. '*' indicates coverage over 99.5%.
 6  WHO-UNICEF estimates.